Risk of progression following a negative biopsy in prostate cancer active surveillance

被引：0
|
作者：
Kerri Beckmann
Aida Santaolalla
Mikio Sugimoto
Peter Carroll
Jose Rubio
Arnauld Villers
Anders Bjartell
Todd Morgan
Prokar Dasgupta
Mieke Van Hemelrijck
Oussama Elhage
机构：
[1] University of South Australia,Cancer Epidemiology and Population Health Research Group
[2] Kings College London,Translational Oncology and Urology Research
[3] Kagawa University,Faculty of Medicine
[4] University of California San Francisco,Department of Urology, UCSF—Helen Diller Comprehensive Cancer Centre
[5] Instituto Valenciano de Oncologia,Department of Urology
[6] Lille University Hospital Center,Immunology and Microbial Sciences
[7] Skane University Hospital,undefined
[8] University of Michigan and Michigan Urological Surgery Improvement Collaborative,undefined
[9] Guy’s and St Thomas’ NHS Foundation Trust,undefined
[10] King’s College London,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2023年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：403 / 409
页数：6
相关论文
共 50 条
  • [41] Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Dall'Era, Marc A.
    Konety, Badrinath R.
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (05): : 277 - 283
  • [42] CONDITIONAL FREEDOM FROM PROGRESSION ON ACTIVE SURVEILLANCE OF PROSTATE CANCER STRATIFIED BY NCCN RISK
    Harvey, Joshua
    Gusev, Andrew
    Rumpf, Florian
    Salari, Keyan
    Twum-Ampofo, Jeffrey
    Wszolek, Matthew
    Dahl, Douglas
    Blute, Michael
    Feldman, Adam
    JOURNAL OF UROLOGY, 2021, 206 : E1096 - E1097
  • [43] Predicting progression in patients followed with active surveillance for low-risk prostate cancer
    Sternberg, Itay Aharon
    Yu, Changhong
    Paz, Gal Elimelech Keren
    Kim, Philip H.
    Bernstein, Melanie
    Lakin, Paul
    Kattan, Michael W.
    Ehdaie, Behdar
    Laudone, Vincent Paul
    Scardino, Peter T.
    Eastham, James Andrew
    Touijer, Karim A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [44] Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Marc A Dall'Era
    Badrinath R Konety
    Nature Clinical Practice Urology, 2008, 5 : 277 - 283
  • [45] Multiparametric prostate MRI and MRI/ultrasound fusion biopsy as tools to follow prostate cancer progression for men on active surveillance
    Shakir, Nabeel
    Walton-Diaz, Annerleim
    Rais-Bahrami, Soroush
    Turkbey, Baris
    Rothwax, Jason
    Hong, Cheng William
    Stamatakis, Lambros
    George, Arvin
    Okoro, Chinonyerem
    Raskolnikov, Dima
    Siddiqui, Minhaj
    Su, Daniel
    Simon, Richard
    Wood, Bradford J.
    Choyke, Peter L.
    Pinto, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [46] Active surveillance in low risk prostate cancer
    Bozkurt, Ozan
    Demir, Omer
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 76 - 79
  • [47] Active Surveillance for Intermediate Risk Prostate Cancer
    Klotz, Laurence
    CURRENT UROLOGY REPORTS, 2017, 18 (10)
  • [48] Active surveillance of low risk prostate cancer
    Lellig, K.
    Beyer, B.
    Graefen, M.
    Zaak, D.
    Stief, C.
    UROLOGE, 2014, 53 (07): : 1031 - 1039
  • [49] Active Surveillance for Intermediate Risk Prostate Cancer
    Laurence Klotz
    Current Urology Reports, 2017, 18
  • [50] ACTIVE SURVEILLANCE IN INTERMEDIATE RISK PROSTATE CANCER
    Chandrasekar, Thenappan
    Herrera-Caceres, Jaime O.
    Klotz, Laurence
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (02): : 157 - 166
12345